For example, To-Figueras et al. 49 found that in congenital erythropoietic porphyria, a disease caused by mutations in UROS (an enzyme of the erythroid heme biosynthesis pathway), severity depends on the variants present in ALAS2, the rate-controlling enzyme of this pathway. Here, ALAS2 is linked to cutaneous porphyria.